Literature DB >> 25871462

Supportive therapy for schizophrenia.

Lucy A Buckley1, Nicola Maayan, Karla Soares-Weiser, Clive E Adams.   

Abstract

BACKGROUND: Supportive therapy is often used in everyday clinical care and in evaluative studies of other treatments.
OBJECTIVES: To review the effects of supportive therapy compared with standard care, or other treatments in addition to standard care for people with schizophrenia. SEARCH
METHODS: For this update, we searched the Cochrane Schizophrenia Group's register of trials (November 2012). SELECTION CRITERIA: All randomised trials involving people with schizophrenia and comparing supportive therapy with any other treatment or standard care. DATA COLLECTION AND ANALYSIS: We reliably selected studies, quality rated these and extracted data. For dichotomous data, we estimated the risk ratio (RR) using a fixed-effect model with 95% confidence intervals (CIs). Where possible, we undertook intention-to-treat analyses. For continuous data, we estimated the mean difference (MD) fixed-effect with 95% CIs. We estimated heterogeneity (I(2) technique) and publication bias. We used GRADE to rate quality of evidence. MAIN
RESULTS: Four new trials were added after the 2012 search. The review now includes 24 relevant studies, with 2126 participants. Overall, the evidence was very low quality.We found no significant differences in the primary outcomes of relapse, hospitalisation and general functioning between supportive therapy and standard care.There were, however, significant differences favouring other psychological or psychosocial treatments over supportive therapy. These included hospitalisation rates (4 RCTs, n = 306, RR 1.82 CI 1.11 to 2.99, very low quality of evidence), clinical improvement in mental state (3 RCTs, n = 194, RR 1.27 CI 1.04 to 1.54, very low quality of evidence) and satisfaction of treatment for the recipient of care (1 RCT, n = 45, RR 3.19 CI 1.01 to 10.7, very low quality of evidence). For this comparison, we found no evidence of significant differences for rate of relapse, leaving the study early and quality of life.When we compared supportive therapy to cognitive behavioural therapy CBT), we again found no significant differences in primary outcomes. There were very limited data to compare supportive therapy with family therapy and psychoeducation, and no studies provided data regarding clinically important change in general functioning, one of our primary outcomes of interest. AUTHORS'
CONCLUSIONS: There are insufficient data to identify a difference in outcome between supportive therapy and standard care. There are several outcomes, including hospitalisation and general mental state, indicating advantages for other psychological therapies over supportive therapy but these findings are based on a few small studies where we graded the evidence as very low quality. Future research would benefit from larger trials that use supportive therapy as the main treatment arm rather than the comparator.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25871462      PMCID: PMC6486211          DOI: 10.1002/14651858.CD004716.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  209 in total

1.  Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia.

Authors:  A Pinto; S La Pia; R Mennella; D Giorgio; L DeSimone
Journal:  Psychiatr Serv       Date:  1999-07       Impact factor: 3.084

2.  Efficacy of a self-esteem module in the empowerment of individuals with schizophrenia.

Authors:  T Lecomte; M Cyr; A D Lesage; J Wilde; C Leclerc; N Ricard
Journal:  J Nerv Ment Dis       Date:  1999-07       Impact factor: 2.254

3.  Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

Authors:  M C Gulliford; O C Ukoumunne; S Chinn
Journal:  Am J Epidemiol       Date:  1999-05-01       Impact factor: 4.897

4.  Intensive case management in Australia: a randomized controlled trial.

Authors:  C Issakidis; K Sanderson; M Teesson; S Johnston; N Buhrich
Journal:  Acta Psychiatr Scand       Date:  1999-05       Impact factor: 6.392

5.  The efficacy of a consumer case management team: 2-year outcomes of a randomized trial.

Authors:  P Solomon; J Draine
Journal:  J Ment Health Adm       Date:  1995

6.  A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis.

Authors:  G Haddock; N Tarrier; A P Morrison; R Hopkins; R Drake; S Lewis
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1999-05       Impact factor: 4.328

7.  Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients--results of a 2-year follow-up.

Authors:  S Klingberg; G Buchkremer; R Holle; H Schulze Mönking; W P Hornung
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

8.  Long-term effects of a psychoeducational psychotherapeutic intervention for schizophrenic outpatients and their key-persons--results of a five-year follow-up.

Authors:  W P Hornung; R Feldmann; S Klingberg; G Buchkremer; T Reker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

9.  A randomized clinical trial of supported employment for inner-city patients with severe mental disorders.

Authors:  R E Drake; G J McHugo; R R Bebout; D R Becker; M Harris; G R Bond; E Quimby
Journal:  Arch Gen Psychiatry       Date:  1999-07

10.  Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS).

Authors:  G Haddock; J McCarron; N Tarrier; E B Faragher
Journal:  Psychol Med       Date:  1999-07       Impact factor: 7.723

View more
  6 in total

1.  Impact of short-term temperature variability on emergency hospital admissions for schizophrenia stratified by season of birth.

Authors:  Desheng Zhao; Xulai Zhang; Zhiwei Xu; Jian Cheng; Mingyu Xie; Heng Zhang; Shusi Wang; Kesheng Li; Huihui Yang; Liying Wen; Xu Wang; Hong Su
Journal:  Int J Biometeorol       Date:  2016-08-18       Impact factor: 3.787

2.  Acceptance and Commitment Therapy for Inpatients with Psychosis (the REACH Study): Protocol for Treatment Development and Pilot Testing.

Authors:  Brandon A Gaudiano; Carter H Davis; Gary Epstein-Lubow; Jennifer E Johnson; Kim T Mueser; Ivan W Miller
Journal:  Healthcare (Basel)       Date:  2017-05-05

3.  Clinical Practice Guidelines for Practice of Supportive Psychotherapy.

Authors:  Sandeep Grover; Ajit Avasthi; Mukesh Jagiwala
Journal:  Indian J Psychiatry       Date:  2020-01-17       Impact factor: 1.759

4.  Non-pharmacological interventions for schizophrenia-analysis of treatment guidelines and implementation in 12 Southeast European countries.

Authors:  Lidija Injac Stevović; Selman Repišti; Tamara Radojičić; Norman Sartorius; Sonila Tomori; Alma Džubur Kulenović; Ana Popova; Martina Rojnić Kuzman; Ilias I Vlachos; Shukrije Statovci; Alexei Bandati; Antoni Novotni; Stojan Bajraktarov; Anca-Livia Panfil; Nadja Maric; Mirjana Delić; Nikolina Jovanović
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-01

5.  Avatar Therapy for people with schizophrenia or related disorders.

Authors:  Ghazaleh Aali; Timothy Kariotis; Farhad Shokraneh
Journal:  Cochrane Database Syst Rev       Date:  2020-05-08

6.  Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials.

Authors:  Irene Bighelli; Georgia Salanti; Cornelia Reitmeir; Sofia Wallis; Corrado Barbui; Toshi A Furukawa; Stefan Leucht
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.